The formation of atherosclerosis is the root cause of
various cardiovascular
diseases (CVDs). Therefore, effective CVD interventions call for precise
identification of the plaques to aid in clinical treatment of such
diseases. Herein, a reactive oxygen species (ROS)-responsive sequentially
targeted fluorescent probe is developed for atherosclerotic plaque
recognition. An aggregation-induced emission active fluorophore is
linked to maleimide (polyethylene glycol) hydroxyl with a ROS-responsive
cleavable bond, which is further functionalized with CLIKKPF peptide
(TPAMCF) for specifically binding to phosphatidylserine of the foam
cells. After being assembled in aqueous medium, TPAMCF nanoparticles
can efficiently accumulate in the plaques through the high affinity
of CLIKKPF to the externalized phosphatidylserine of the foam cells.
Activated by the locally accumulated ROS in foam cells, the nanoparticles
are interrupted, and then TPA can be released and subsequently identify
the lipid droplets inside the foam cells to achieve fluorescence imaging
of the plaques. Such nanoprobes have the favorable ROS response performance
and exhibit a special target binding to the foam cells in
vitro. In addition, nanoprobe-based fluorescence imaging
permitted the high-contrast and precise detection of atherosclerosis
specimens ex vivo. Therefore, as a promising fluorescent
probe, TPAMCF is capable of being a potential candidate for the detection
of atherosclerotic plaque.